Target intelligence / Profile preview

Neutrophil azurophilic granule membrane

Molecular classification
Organelle membrane, Cellular compartment, Other
01

Overview

Neutrophil azurophilic granule membranes are the lipid bilayers that sequester the primary, or azurophilic, granules within neutrophil granulocytes (Source: PubMed PMID: 24663157). These granules function as specialized lysosomes, containing a high concentration of cytotoxic and hydrolytic enzymes such as myeloperoxidase (MPO), neutrophil elastase (NE), and proteinase 3 (PR3), which are essential for the intracellular destruction of pathogens (Source: StatPearls, Neutrophil Function). The membrane is characterized by the presence of specific proteins like CD63 (LAMP-3), which serves as a marker for degranulation when expressed on the cell surface (Source: UniProt P08962). It plays a pivotal role in the process of degranulation, where the granule fuses with the phagosome or the plasma membrane to release its contents during an immune response. Dysregulation of these membranes or the premature release of granule contents is a hallmark of various inflammatory conditions and autoimmune disorders, notably ANCA-associated vasculitis, where autoantibodies target granule components (Source: NIH/NCBI, ANCA-Associated Vasculitis). Therapeutic strategies often involve stabilizing these membranes or inhibiting the released enzymes using drugs like colchicine or corticosteroids to mitigate collateral tissue damage (Source: PubMed PMID: 10891102).

Other names
Primary granule membraneNeutrophil lysosomal membraneAzurophil granule membrane
02

Mechanism of action

Stabilization of lysosomal membranes and inhibition of microtubule-mediated degranulation to prevent the release of cytotoxic enzymes.

03

Biological functions

Immune responseDegranulationPhagocytosisAntimicrobial activityOther
04

Disease associations

InflammationInfectionANCA-associated vasculitisChronic obstructive pulmonary disease (COPD)Rheumatoid arthritisOther
05

Safety considerations

ImmunosuppressionIncreased susceptibility to bacterial and fungal infectionsImpaired wound healing
06

Interacting drugs

Colchicine

3 more in the full profile.

07

Biomarkers

CD63 (LAMP-3)Myeloperoxidase (MPO)Neutrophil elastase (NE)Proteinase 3 (PR3)

Beyond the preview

Go deeper on Neutrophil azurophilic granule membrane.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neutrophil azurophilic granule membrane.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call